Andrew Tran

Emory University

Papers

1

Total Citations

11

H-Index

1

About

Dr. Andrew Tran is a leading researcher in thoracic oncology, with a primary focus on optimizing treatment strategies for early-stage non-small cell lung cancer (NSCLC). His work critically evaluates and compares the efficacy of surgical resection, radiotherapy, and emerging minimally invasive techniques such as percutaneous thermal ablation. Dr. Tran’s major contribution includes the development of a rigorous systematic review and network meta-analysis protocol that synthesizes evidence across these modalities, aiming to establish clearer, evidence-based guidelines for stage 1 NSCLC management. This foundational work, cited 11 times, addresses the growing clinical challenge of treating medically complex patients who may not be ideal surgical candidates. By systematically comparing outcomes, Dr. Tran’s research helps clinicians weigh the risks and benefits of each approach, potentially expanding access to effective, less invasive treatments. His efforts are instrumental in shaping future clinical trials and informing multidisciplinary decision-making, ultimately striving to improve survival and quality of life for lung cancer patients.

Research Focus

Key Achievements

1
H-Index
1
Papers
11
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Surgical resection, radiotherapy and percutaneous thermal ablation for treatment of stage 1 non-small cell lung cancer: protocol for a systematic review and network meta-analysis
11 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Emory University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago